U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 240

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr15:40762842
GRCh38:
Chr15:40470643
CHST14not providedBenign
(Jun 18, 2018)
criteria provided, single submitter
2.
GRCh37:
Chr15:40762862
GRCh38:
Chr15:40470663
CHST14not providedBenign
(Jul 14, 2018)
criteria provided, single submitter
3.
GRCh37:
Chr15:40762879
GRCh38:
Chr15:40470680
CHST14not providedLikely benign
(Jun 14, 2018)
criteria provided, single submitter
4.
GRCh37:
Chr15:40763228
GRCh38:
Chr15:40471029
CHST14not providedLikely benign
(May 19, 2019)
criteria provided, single submitter
5.
GRCh37:
Chr15:40763386
GRCh38:
Chr15:40471187
CHST14not specifiedLikely benign
(Aug 18, 2017)
criteria provided, single submitter
6.
GRCh37:
Chr15:40763408
GRCh38:
Chr15:40471209
CHST14not specifiedLikely benign
(Nov 4, 2016)
criteria provided, single submitter
7.
GRCh37:
Chr15:40763414
GRCh38:
Chr15:40471215
CHST14M1TEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Nov 2, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr15:40763420
GRCh38:
Chr15:40471221
CHST14P3LEhlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotypeUncertain significance
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr15:40763423
GRCh38:
Chr15:40471224
CHST14R4PEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(May 10, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr15:40763432
GRCh38:
Chr15:40471233
CHST14T7NEhlers-Danlos syndrome, musculocontractural type, Ehlers-Danlos syndrome, musculocontractural type 1Uncertain significance
(Oct 4, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr15:40763435
GRCh38:
Chr15:40471236
CHST14P8LCardiovascular phenotypeUncertain significance
(Oct 21, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr15:40763444
GRCh38:
Chr15:40471245
CHST14A11VEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Aug 9, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr15:40763446
GRCh38:
Chr15:40471247
CHST14P12SCardiovascular phenotypeUncertain significance
(Sep 9, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr15:40763449
GRCh38:
Chr15:40471250
CHST14N13DCardiovascular phenotypeUncertain significance
(Aug 27, 2020)
criteria provided, single submitter
15.
GRCh37:
Chr15:40763455
GRCh38:
Chr15:40471256
CHST14A15SCardiovascular phenotypeUncertain significance
(Aug 7, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr15:40763455
GRCh38:
Chr15:40471256
CHST14A15PCardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural typeUncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr15:40763457
GRCh38:
Chr15:40471258
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Feb 5, 2020)
criteria provided, single submitter
18.
GRCh37:
Chr15:40763458
GRCh38:
Chr15:40471259
CHST14E16Knot providedUncertain significance
(Jan 17, 2020)
criteria provided, single submitter
19.
GRCh37:
Chr15:40763460
GRCh38:
Chr15:40471261
CHST14E16DCardiovascular phenotypeUncertain significance
(Oct 23, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr15:40763460
GRCh38:
Chr15:40471261
CHST14Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Jun 14, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr15:40763461
GRCh38:
Chr15:40471262
CHST14P17SCardiovascular phenotypeUncertain significance
(Aug 3, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr15:40763470
GRCh38:
Chr15:40471271
CHST14R20WCardiovascular phenotype, not provided, Ehlers-Danlos syndrome, musculocontractural type
Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr15:40763471
GRCh38:
Chr15:40471272
CHST14R20PCardiovascular phenotypeUncertain significance
(May 24, 2021)
criteria provided, single submitter
24.
GRCh37:
Chr15:40763473
GRCh38:
Chr15:40471274
CHST14A21SCardiovascular phenotypeUncertain significance
(Nov 9, 2021)
criteria provided, single submitter
25.
GRCh37:
Chr15:40763473
GRCh38:
Chr15:40471274
CHST14A21TEhlers-Danlos syndrome, musculocontractural type 1Uncertain significance
(Jan 24, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr15:40763477
GRCh38:
Chr15:40471278
CHST14L22PEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Oct 13, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr15:40763483
GRCh38:
Chr15:40471284
CHST14R24LCardiovascular phenotypeUncertain significance
(Nov 9, 2021)
criteria provided, single submitter
28.
GRCh37:
Chr15:40763485
GRCh38:
Chr15:40471286
CHST14A25SCardiovascular phenotypeUncertain significance
(Oct 23, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr15:40763486
GRCh38:
Chr15:40471287
CHST14A25Dnot providedUncertain significance
(Apr 18, 2017)
criteria provided, single submitter
30.
GRCh37:
Chr15:40763489
GRCh38:
Chr15:40471290
CHST14P26LEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Oct 16, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr15:40763506
GRCh38:
Chr15:40471307
CHST14A32PCardiovascular phenotypeUncertain significance
(Nov 14, 2021)
criteria provided, single submitter
32.
GRCh37:
Chr15:40763511
GRCh38:
Chr15:40471312
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Oct 20, 2021)
criteria provided, single submitter
33.
GRCh37:
Chr15:40763516
GRCh38:
Chr15:40471317
CHST14G35AEhlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotypeUncertain significance
(Jun 24, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr15:40763523
GRCh38:
Chr15:40471324
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Mar 3, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr15:40763523
GRCh38:
Chr15:40471324
CHST14Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Feb 14, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr15:40763526
GRCh38:
Chr15:40471327
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Sep 23, 2021)
criteria provided, single submitter
37.
GRCh37:
Chr15:40763527
GRCh38:
Chr15:40471328
CHST14not providedLikely benign
(Jul 31, 2018)
criteria provided, single submitter
38.
GRCh37:
Chr15:40763529
GRCh38:
Chr15:40471330
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Jan 27, 2021)
criteria provided, single submitter
39.
GRCh37:
Chr15:40763537
GRCh38:
Chr15:40471338
CHST14P42LCardiovascular phenotypeUncertain significance
(Mar 23, 2021)
criteria provided, single submitter
40.
GRCh37:
Chr15:40763537
GRCh38:
Chr15:40471338
CHST14P42Rnot providedUncertain significance
(Aug 22, 2017)
criteria provided, single submitter
41.
GRCh37:
Chr15:40763542
GRCh38:
Chr15:40471343
CHST14M44VEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Aug 20, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr15:40763546
GRCh38:
Chr15:40471347
CHST14L45Rnot providedUncertain significance
(Feb 7, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr15:40763547
GRCh38:
Chr15:40471348
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Sep 24, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr15:40763550
GRCh38:
Chr15:40471351
CHST14M46IEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
45.
GRCh37:
Chr15:40763555
GRCh38:
Chr15:40471356
CHST14A48VEhlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype, not provided
Uncertain significance
(Mar 25, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr15:40763556
GRCh38:
Chr15:40471357
CHST14not provided, Ehlers-Danlos syndrome, musculocontractural typeConflicting interpretations of pathogenicity
(May 17, 2021)
criteria provided, conflicting interpretations
47.
GRCh37:
Chr15:40763560
GRCh38:
Chr15:40471361
CHST14I50FEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr15:40763563
GRCh38:
Chr15:40471364
CHST14V51MEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
49.
GRCh37:
Chr15:40763563
GRCh38:
Chr15:40471364
CHST14V51Lnot provided, Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype
Likely benign
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr15:40763565-40763575
GRCh38:
Chr15:40471366-40471376
CHST14S53fsEhlers-Danlos syndrome, musculocontractural type, not providedPathogenic/Likely pathogenic
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr15:40763567
GRCh38:
Chr15:40471368
CHST14A52VEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Mar 18, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr15:40763570
GRCh38:
Chr15:40471371
CHST14S53YEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Sep 6, 2018)
criteria provided, single submitter
53.
GRCh37:
Chr15:40763571-40763572
GRCh38:
Chr15:40471372-40471373
CHST14S54fsEhlers-Danlos syndrome, musculocontractural typePathogenic
(Aug 10, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr15:40763583
GRCh38:
Chr15:40471384
CHST14L58fsEhlers-Danlos syndrome, musculocontractural typePathogenic
(Aug 28, 2021)
criteria provided, single submitter
55.
GRCh37:
Chr15:40763585
GRCh38:
Chr15:40471386
CHST14L58PEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Sep 15, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr15:40763586
GRCh38:
Chr15:40471387
CHST14not providedLikely benign
(Mar 30, 2018)
criteria provided, single submitter
57.
GRCh37:
Chr15:40763592
GRCh38:
Chr15:40471393
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Oct 7, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr15:40763595
GRCh38:
Chr15:40471396
CHST14E61DCardiovascular phenotypeUncertain significance
(May 24, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr15:40763595
GRCh38:
Chr15:40471396
CHST14not providedLikely benign
(Jun 26, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr15:40763600
GRCh38:
Chr15:40471401
CHST14G63Dnot providedUncertain significance
(Nov 5, 2020)
criteria provided, single submitter
61.
GRCh37:
Chr15:40763601
GRCh38:
Chr15:40471402
CHST14Cardiovascular phenotypeLikely benign
(May 20, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr15:40763601
GRCh38:
Chr15:40471402
CHST14Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotypeLikely benign
(Jun 4, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr15:40763608
GRCh38:
Chr15:40471409
CHST14A66TEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr15:40763610
GRCh38:
Chr15:40471411
CHST14Cardiovascular phenotype, not provided, Ehlers-Danlos syndrome, musculocontractural type
Conflicting interpretations of pathogenicity
(Jun 14, 2022)
criteria provided, conflicting interpretations
65.
GRCh37:
Chr15:40763614
GRCh38:
Chr15:40471415
CHST14M68VEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(May 7, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr15:40763617
GRCh38:
Chr15:40471418
CHST14K69*Ehlers-Danlos syndrome, musculocontractural type 1Pathogenic
(Aug 1, 2010)
no assertion criteria provided
67.
GRCh37:
Chr15:40763622
GRCh38:
Chr15:40471423
CHST14Ehlers-Danlos syndrome, musculocontractural typeBenign
(Oct 15, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr15:40763629
GRCh38:
Chr15:40471430
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Apr 26, 2020)
criteria provided, single submitter
69.
GRCh37:
Chr15:40763636
GRCh38:
Chr15:40471437
CHST14P75Qnot providedUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
70.
GRCh37:
Chr15:40763640
GRCh38:
Chr15:40471441
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Mar 29, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr15:40763651
GRCh38:
Chr15:40471452
CHST14G80Dnot provided, Ehlers-Danlos syndrome, musculocontractural typeUncertain significance
(Nov 15, 2021)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr15:40763657
GRCh38:
Chr15:40471458
CHST14A82GEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Aug 14, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr15:40763662
GRCh38:
Chr15:40471463
CHST14R84SEhlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotypeUncertain significance
(May 10, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr15:40763664
GRCh38:
Chr15:40471465
CHST14not provided, Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Sep 7, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr15:40763667
GRCh38:
Chr15:40471468
CHST14Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Jul 27, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr15:40763672
GRCh38:
Chr15:40471473
CHST14K89fsEhlers-Danlos syndrome, musculocontractural typePathogenic
(May 31, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr15:40763683
GRCh38:
Chr15:40471484
CHST14G92fsnot providedLikely pathogenic
(Sep 1, 2016)
criteria provided, single submitter
78.
GRCh37:
Chr15:40763687
GRCh38:
Chr15:40471488
CHST14G92VEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr15:40763695
GRCh38:
Chr15:40471496
CHST14L95FEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Aug 24, 2021)
criteria provided, single submitter
80.
GRCh37:
Chr15:40763700
GRCh38:
Chr15:40471501
CHST14Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype, not provided,
not specified
Benign/Likely benign
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr15:40763705
GRCh38:
Chr15:40471506
CHST14G98ECardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural typeUncertain significance
(Aug 14, 2021)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr15:40763706
GRCh38:
Chr15:40471507
CHST14Cardiovascular phenotypeLikely benign
(Apr 3, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr15:40763707
GRCh38:
Chr15:40471508
CHST14D99NEhlers-Danlos syndrome, musculocontractural type, Ehlers-Danlos syndrome, musculocontractural type 1Uncertain significance
(Aug 24, 2021)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr15:40763709
GRCh38:
Chr15:40471510
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Jul 29, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr15:40763711
GRCh38:
Chr15:40471512
CHST14A100VEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Jun 13, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr15:40763713
GRCh38:
Chr15:40471514
CHST14D101Nnot providedUncertain significance
(Feb 13, 2023)
criteria provided, single submitter
87.
GRCh37:
Chr15:40763715
GRCh38:
Chr15:40471516
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Sep 19, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr15:40763722
GRCh38:
Chr15:40471523
CHST14V104Mnot providedUncertain significance
(Dec 6, 2021)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr15:40763727
GRCh38:
Chr15:40471528
CHST14Cardiovascular phenotypeLikely benign
(Oct 2, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr15:40763727
GRCh38:
Chr15:40471528
CHST14Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type 1, Ehlers-Danlos syndrome, musculocontractural type
Conflicting interpretations of pathogenicity
(Jul 25, 2022)
criteria provided, conflicting interpretations
91.
GRCh37:
Chr15:40763730
GRCh38:
Chr15:40471531
CHST14Ehlers-Danlos syndromeUncertain significance
(Sep 25, 2020)
criteria provided, single submitter
92.
GRCh37:
Chr15:40763737
GRCh38:
Chr15:40471538
CHST14R109WEhlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotypeUncertain significance
(Aug 24, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr15:40763790
GRCh38:
Chr15:40471591
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Sep 27, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr15:40763794
GRCh38:
Chr15:40471595
CHST14D128HEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Feb 20, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr15:40763802
GRCh38:
Chr15:40471603
CHST14Cardiovascular phenotypeLikely benign
(Feb 12, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr15:40763810
GRCh38:
Chr15:40471611
CHST14Q133Pnot provided, Ehlers-Danlos syndrome, Ehlers-Danlos syndrome, musculocontractural type
Uncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr15:40763812
GRCh38:
Chr15:40471613
CHST14R134WEhlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotypeUncertain significance
(May 16, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr15:40763813
GRCh38:
Chr15:40471614
CHST14R134QEhlers-Danlos syndrome, musculocontractural typeUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
99.
GRCh37:
Chr15:40763815
GRCh38:
Chr15:40471616
CHST14R135Gno interpretation for the single variantno interpretation for the single variant
100.
GRCh37:
Chr15:40763821
GRCh38:
Chr15:40471622
CHST14Ehlers-Danlos syndrome, musculocontractural typeLikely benign
(Nov 20, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination